


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:04:27Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406449" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406449</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>aidsresther</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">AIDS Res Ther</journal-id><journal-id journal-id-type="iso-abbrev">AIDS Res Ther</journal-id><journal-id journal-id-type="pmc-domain-id">306</journal-id><journal-id journal-id-type="pmc-domain">aidsresther</journal-id><journal-title-group><journal-title>AIDS Research and Therapy</journal-title></journal-title-group><issn pub-type="epub">1742-6405</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406449</article-id><article-id pub-id-type="pmcid-ver">PMC12406449.1</article-id><article-id pub-id-type="pmcaid">12406449</article-id><article-id pub-id-type="pmcaiid">12406449</article-id><article-id pub-id-type="pmid">40898300</article-id><article-id pub-id-type="doi">10.1186/s12981-025-00757-1</article-id><article-id pub-id-type="publisher-id">757</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Hypoalbuminemia in HIV-infected patients: its determinants and correlation with CD4 count in Northern Uganda</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0005-8710-8421</contrib-id><name name-style="western"><surname>Ahmed</surname><given-names initials="AA">Abukar Ali</given-names></name><address><email>ahmed.abukar@studwc.kiu.ac.ug</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0005-2161-7290</contrib-id><name name-style="western"><surname>Hassan</surname><given-names initials="HA">Hanan Asad</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0009-9362-9943</contrib-id><name name-style="western"><surname>Mswelo</surname><given-names initials="VE">Venance Emmanuel</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0001-1983-3470</contrib-id><name name-style="western"><surname>Abdi</surname><given-names initials="AA">Awil Abdulkadir</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nixson</surname><given-names initials="O">Onyanga</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Omar</surname><given-names initials="HMS">Hanaa Mohamed Shiekh</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0008-2204-0384</contrib-id><name name-style="western"><surname>Jayte</surname><given-names initials="M">Mohamed</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Musa</surname><given-names initials="ME">Mohamed Elmalik</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0002-0188-6512</contrib-id><name name-style="western"><surname>Hirsi</surname><given-names initials="AM">Abishir Mohamud</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/017g82c94</institution-id><institution-id institution-id-type="GRID">grid.440478.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0648 1247</institution-id><institution>Department of Internal Medicine, Faculty of Clinical Medicine and Dentistry, </institution><institution>Kampala International University, </institution></institution-wrap>Ishaka, Bushenyi, Uganda </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>22</volume><issue-id pub-id-type="pmc-issue-id">478378</issue-id><elocation-id>88</elocation-id><history><date date-type="received"><day>18</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>3</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="12981_2025_Article_757.pdf"/><abstract id="Abs1"><sec><title>Introduction</title><p id="Par1">Hypoalbuminemia is linked to an earlier onset of acquired immune deficiency syndrome and increased mortality in patients living with HIV infection. Serum albumin is therefore an independent factor for the prediction of disease progression and mortality in People Living With HIV.</p></sec><sec><title>Methods</title><p id="Par2">This was a cross-sectional study conducted at Lira Regional Referral Hospital in northern Uganda that targeted HIV-positive outpatients attending the ART clinic with a sample size of 373 patients. Data were collected through structured interviews and laboratory tests in which the serum albumin concentration, viral load, and CD4 count were measured.</p></sec><sec><title>Results</title><p id="Par3">The prevalence of hypoalbuminemia was 19.6% (73/373). A moderate positive correlation was observed between the serum albumin concentration and the CD4 count (rs&#8201;=&#8201;0.43, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). Patients with no formal education [AOR&#8201;=&#8201;2.03, 95%CI&#8201;=&#8201;1.69&#8211;2.07, <italic toggle="yes">P</italic>&#8201;=&#8201;0.03] were 2.03 times more likely to have hypoalbuminemia than those who had a tertiary/university education level. The odds of having hypoalbuminemia [AOR&#8201;=&#8201;2.17, CI&#8201;=&#8201;1.80&#8211;3.06, <italic toggle="yes">P</italic>&#8201;=&#8201;0.02] were 2.17 higher among HIV-infected patients who were na&#239;ve ART than among those who were on ART. Additionally, the odds of having hypoalbuminemia [AOR&#8201;=&#8201;2.91, CI&#8201;=&#8201;2.13&#8211;3.66, <italic toggle="yes">P</italic>&#8201;=&#8201;0.01] were 2.91 higher among HIV-infected patients who were in stage four than among those who were in stage 1.</p></sec><sec><title>Conclusion</title><p id="Par4">Hypoalbuminemia prevalence was high in PLWHIV, and a moderate positive correlation was found between the serum albumin level and the CD4 cell count. Lower education level, not being ART, and advanced HIV disease were independently associated with hypoalbuminemia.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12981-025-00757-1.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Hypoalbuminemia</kwd><kwd>AIDS</kwd><kwd>HIV</kwd><kwd>CD4 cell count</kwd><kwd>Correlation</kwd><kwd>ART</kwd><kwd>Viral load</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Recent studies have suggested the use of serum albumin level as a predictor marker of Human Immunodeficiency Virus disease severity and mortality in People Living With HIV [<xref ref-type="bibr" rid="CR1">1</xref>]. A single measurement of albumin at baseline has been found to be useful in predicting survival of PLWHIV, especially those with CD4 counts&#8201;&lt;&#8201;200 cells [<xref ref-type="bibr" rid="CR2">2</xref>]. Several factors contribute to the development of hypoalbuminemia in PLWHIV, such as increased albumin leakage during inflammatory response disease due to chronic inflammation, increased transcapillary escape of albumin due to impaired barrier function of the endothelium caused by the HIV-1 Tat1 protein, HIV infection-induced liver damage, diminished microbial clearance, impaired or decreased protein synthesis that enhances inflammation and reduced food intake due to decreased appetite [<xref ref-type="bibr" rid="CR3">3</xref>&#8211;<xref ref-type="bibr" rid="CR5">5</xref>]. Albumin can also be lost through urine (microalbuminuria) due to HIV-associated nephropathy in PLWHIV [<xref ref-type="bibr" rid="CR6">6</xref>]. Serum albumin concentrations less than 3.5&#160;g/dL are referred to as hypoalbuminemia [<xref ref-type="bibr" rid="CR7">7</xref>]. The prevalence of hypoalbuminemia in HIV-positive individuals ranges from 5.9&#8211;39.5%<sup>5</sup>.</p><p id="Par6">This condition has significant clinical implications, as it has been notably linked to earlier onset of acquired immune deficiency syndrome and increased mortality [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. A study found that for every 2.5&#160;mg/L decrease in the serum albumin concentration, there is a corresponding 16% and 39% increase in the likelihood of an extended hospital stay and an increased chance of mortality, respectively, in critically ill inpatients, including patients with HIV/AIDS [<xref ref-type="bibr" rid="CR9">9</xref>]. The risk of mortality in PLWHIV is 4.52 times higher for people with hypoalbuminemia than for those with serum albumin values&#8201;&#8805;&#8201;3.5&#160;g/L<sup>10</sup>. Additionally, the risk of mortality in PLWHIV decreased by 6% with every 1&#160;g/L increase in the serum albumin concentration [<xref ref-type="bibr" rid="CR11">11</xref>]. Several studies revealed a positive correlation between the serum albumin concentration and the CD4 count [<xref ref-type="bibr" rid="CR12">12</xref>&#8211;<xref ref-type="bibr" rid="CR14">14</xref>]. Furthermore, studies reported that serum albumin is a useful prognostic marker for HIV/AIDS care and independent predictor marker of non-AIDS morbidity in PLWH, such as cardiovascular diseases [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. While there is a dearth of knowledge regarding hypoalbuminemia and its utilization as a prognostic marker in HIV/AIDS care in Uganda. Our study provides the first comprehensive evaluation of hypoalbuminemia in PLWHIV in northern Uganda. A better understanding of hypoalbuminemia and its immune-virological correlations and associated factors can aid in identifying high-risk populations and tailoring interventions accordingly [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR16">16</xref>&#8211;<xref ref-type="bibr" rid="CR19">19</xref>]. This study seeks to determine the correlation between serum albumin and CD4 cell count, and identify the determinants of hypoalbuminemia in PLWHIV.</p></sec><sec id="Sec2"><title>Methodology</title><sec id="Sec3"><title>Study design</title><p id="Par7">This study was a cross-sectional study.</p></sec><sec id="Sec4"><title>Study setting</title><p id="Par8">The study was carried out in Northern Uganda&#8217;s Lira district at the Lira Regional Referral Hospital. LRRH has ART clinics and provides antiretroviral therapy (ART) services, including care through units with integrated HIV services and community drug distribution. Currently, there are more than 12,000 HIV/AIDS clients receiving HAART [<xref ref-type="bibr" rid="CR20">20</xref>].</p></sec><sec id="Sec5"><title>Inclusion criteria</title><p id="Par9">The study included all HIV-positive patients aged 18 years and above attending the ART Clinic at Lira Regional Referral Hospital and who provided consent to participate in the study.</p></sec><sec id="Sec6"><title>Exclusion criteria</title><p id="Par10">All patients living with HIV who met the inclusion criteria but were severely ill and had known liver disease or kidney disease were excluded from the study.</p></sec><sec id="Sec7"><title>Sample size estimation</title><p id="Par11">Leslie Kish&#8217;s formula was used to determine the sample size of 373 participants for this study.</p><p id="Par12">Leslie Kish&#8217;s formula for determining sample size in a finite population was used:</p><p id="Par13"><inline-formula id="IEq1"><alternatives><tex-math id="d33e312">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\:n=\frac{{n}_{0}}{1+\frac{{n}_{0}-1}{N}}$$\end{document}</tex-math><inline-graphic xlink:href="12981_2025_757_Article_IEq1.gif"/></alternatives></inline-formula>where:</p><p id="Par14">n&#8201;=&#8201;final sample size adjusted for finite.</p><p id="Par15">population.</p><p id="Par16">n<sub>0</sub>&#8201;=&#8201;initial sample size (for an infinite.</p><p id="Par17">population)</p><p id="Par18">N&#8201;=&#8201;total population size.</p><p id="Par19">where:</p><p id="Par20">
<list list-type="bullet"><list-item><p id="Par21">n<sub>0</sub> is the sample size for an infinite population, calculated as:</p></list-item></list>
<disp-formula id="Equa"><alternatives><tex-math id="d33e341">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${n_0} = \frac{{{z^2}P(1 - P)}}{{{d^2}}}$$\end{document}</tex-math><graphic position="anchor" orientation="portrait" xlink:href="12981_2025_757_Article_Equa.gif"/></alternatives></disp-formula>
</p><p id="Par22">Where.</p><p id="Par23">&#8226; n<sub>0</sub> is the sample size for an infinite population.</p><p id="Par24">&#8226; Z is the Z-score corresponding to the confidence level (typically 1.96 for 95% confidence).</p><p id="Par25">&#8226; P is the assumed proportion of the population (50% or 0.5).</p><p id="Par26">&#8226; d is the margin of error (commonly 5% or 0.05).</p><p id="Par27">The sample size for this study was determined by calculating the predicted prevalence of 50%, as no recent study had been conducted in the local regions. The value utilized for P in the calculation was 0.5.</p><p id="Par28">The required sample size for a finite population of 12,000, using Leslie Kish&#8217;s formula with a 50% population proportion and a 5% margin of error, is approximately <bold>373</bold> respondents.</p></sec><sec id="Sec8"><title>Sampling procedure</title><p id="Par29">The PI employed a systematic random sampling technique for this study. Lira Regional Referral Hospital has multiple ART clinics for outpatients. On average, 1000 patients visit the clinic monthly to seek service. To get the sampling interval, the PI divided 373 study responders by 3000(average patients visit 3 in months), giving about 8 persons. This implies that the PI selected the study participants at an interval of three (every 8th patient with HIV voluntarily participated in the study daily). The first study participant was randomly selected from this, then followed participants were selected by adding the sampling interval 8 to the previous selection, continuing this process until all actual participants (373) were obtained.</p></sec><sec id="Sec81"><title>Recruitment of research assistants</title><p id="Par30">The research assistants included 1 nurse, 1 clinical officer, and 2 lab technicians working at the LRRH ART clinic. Their role was to assist the principal investigator (PI). The nurses also obtained blood samples from the participants. The role of the lab technicians was to facilitate blood sample collection and transport those samples to the laboratory safely and appropriately for analysis at the main laboratory. A full day of training was provided to the research assistants, covering research methodology, data collection techniques and instruments, ethics, and code of conduct.</p></sec><sec id="Sec811"><title>Study procedure</title><p id="Par31">The principal investigator and his assistant screened HIV-positive patients from the LRRH-ART clinic. The participants were chosen at random, all eligible participants were provided additional information about the research project, including risks and benefits. The participants were asked to sign a written informed consent document indicating their willingness to participate. After obtaining the informed consent focused history and physical examination were performed by the principal investigator (PI), and the findings were recorded on a pretested questionnaire. Blood sample (10&#160;ml) were drawn from each participant&#8217;s median cubital vein and distributed as follows: 4&#160;ml into EDTA Tube for HIV VL, 3&#160;ml into a red top tube for serum albumin, and 3&#160;ml into a purple top for CD4 cell count). The samples were sent to both the ART clinic laboratory and the main central laboratory LRRH. CD4 cell count was measured using the PIMA&#8482; analyzer, and serum albumin was measured using the Coba311 biochemistry analyzer, and HIV VL was sent to the main central laboratory of LRRH.</p></sec></sec><sec id="Sec9"><title>Study variables</title><sec id="Sec8111"><title>Independent variables</title><p id="Par32"><bold>Sociodemographic factors such as</bold> age, sex, area of residence, marital status, level of education, occupation, and level of income.</p><p id="Par33"><bold>Medical factors such as</bold> WHO Staging of HIV, BMI, Duration of HIV infection, current duration on ART, drug adherence, CD4 cell count, and HIV Viral Load.</p></sec><sec id="Sec10"><title>Dependent variable</title><p id="Par34">The dependent variable for this study was hypoalbuminemia among patients living with HIV.</p></sec><sec id="Sec11"><title>Quality control</title><p id="Par35">The data collection tool was pretested for validity and reliability, and adjustments were made before data collection. Research assistants were trained on the study objectives and protocol. The principal investigator double-checked the data daily for accuracy. Quality control measures included regular calibration of laboratory equipment, to control the material, and random samples were sent to the main laboratory (Lira Regional Referral Hospital an officer took those samples to the Laboratory with appropriate transportation).</p></sec><sec id="Sec12"><title>Data management and analysis</title><p id="Par36">Microsoft Excel was used for entering the data. This was input twice and checked for errors via validation. For the final analysis, the data was exported to STATA version 16. The data was saved in storage devices and kept in various safe locations. Descriptive statistics were used for prevalence determination and presented as percentage with 95% confidence intervals. Spearman&#8217;s rank correlation coefficient was used to determine the correlation between the serum albumin concentration and the CD4 count. Both bivariate and multivariable logistic regression were used to identify the factors associated with hypoalbuminemia. A factor was taken into consideration for multivariable analysis if a p value of less than 0.2 was obtained during bivariate analysis. Multivariate logistic regression analysis was used to evaluate confounding factors and interactions. Statistical significance was accorded to factors that presented p values of less than 5% during multivariable analysis.</p></sec><sec id="Sec13"><title>Study limitations</title><p id="Par37">This study was a cross-sectional design limits causal inferences, and the single-center setting may restrict generalizability.</p></sec></sec><sec id="Sec14"><title>Results</title><sec id="Sec134"><title>Sociodemographic and clinical characteristics of the patients with HIV attending ART clinic LRRH</title><p id="Par38">The study enrolled 373 HIV-positive patients from the ART clinic Lira Regional Referral Hospital during the study period between the 1st October and 31st December 2024.</p><p id="Par39">As summarized in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>, the majority of patients were male, 54.7% (204/373), and nearly one-third, 32.7% (122/373), had no formal education. Most of the patients (71.0%, 265/373) were on ART, and 45.6% (170/373) were classified as WHO HIV stage 1.</p><p id="Par40">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Sociodemographic and clinical characteristics of HIV-infected patients attending the ART clinic at Lira regional referral Hospital(<italic toggle="yes">N</italic>&#8201;=&#8201;373)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variables</th><th align="left" colspan="1" rowspan="1">Frequencies (<italic toggle="yes">N</italic>&#8201;=&#8201;373)</th><th align="left" colspan="1" rowspan="1">Percentage (%)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<bold>Age categories (years)</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;30</td><td char="." align="char" colspan="1" rowspan="1">96</td><td align="left" colspan="1" rowspan="1">25.7</td></tr><tr><td align="left" colspan="1" rowspan="1">31&#8211;40</td><td char="." align="char" colspan="1" rowspan="1">105</td><td align="left" colspan="1" rowspan="1">28.2</td></tr><tr><td align="left" colspan="1" rowspan="1">41&#8211;50</td><td char="." align="char" colspan="1" rowspan="1">93</td><td align="left" colspan="1" rowspan="1">24.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&gt;&#8201;50</td><td char="." align="char" colspan="1" rowspan="1">79</td><td align="left" colspan="1" rowspan="1">21.2</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Sex</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Male</td><td char="." align="char" colspan="1" rowspan="1">204</td><td align="left" colspan="1" rowspan="1">54.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Female</td><td char="." align="char" colspan="1" rowspan="1">169</td><td align="left" colspan="1" rowspan="1">45.3</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Occupation</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Employed</td><td char="." align="char" colspan="1" rowspan="1">121</td><td align="left" colspan="1" rowspan="1">32.4</td></tr><tr><td align="left" colspan="1" rowspan="1">Unemployed</td><td char="." align="char" colspan="1" rowspan="1">252</td><td align="left" colspan="1" rowspan="1">67.6</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Education level</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Tertiary/University</td><td char="." align="char" colspan="1" rowspan="1">68</td><td align="left" colspan="1" rowspan="1">18.2</td></tr><tr><td align="left" colspan="1" rowspan="1">Secondary</td><td char="." align="char" colspan="1" rowspan="1">103</td><td align="left" colspan="1" rowspan="1">27.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Primary</td><td char="." align="char" colspan="1" rowspan="1">80</td><td align="left" colspan="1" rowspan="1">21.4</td></tr><tr><td align="left" colspan="1" rowspan="1">No formal education</td><td char="." align="char" colspan="1" rowspan="1">122</td><td align="left" colspan="1" rowspan="1">32.7</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Marital status</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Married</td><td char="." align="char" colspan="1" rowspan="1">150</td><td align="left" colspan="1" rowspan="1">40.2</td></tr><tr><td align="left" colspan="1" rowspan="1">Single</td><td char="." align="char" colspan="1" rowspan="1">126</td><td align="left" colspan="1" rowspan="1">33.8</td></tr><tr><td align="left" colspan="1" rowspan="1">Divorced/widowed</td><td char="." align="char" colspan="1" rowspan="1">97</td><td align="left" colspan="1" rowspan="1">26.0</td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>BMI</bold> kg/m2</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;18.5 (underweight)</td><td char="." align="char" colspan="1" rowspan="1">35</td><td align="left" colspan="1" rowspan="1">9.4</td></tr><tr><td align="left" colspan="1" rowspan="1">18.5&#8211;24.9 (normal)</td><td char="." align="char" colspan="1" rowspan="1">197</td><td align="left" colspan="1" rowspan="1">52.8</td></tr><tr><td align="left" colspan="1" rowspan="1">25-29.9(overweight)</td><td char="." align="char" colspan="1" rowspan="1">93</td><td align="left" colspan="1" rowspan="1">24.9</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8805;&#8201;30(obese)</td><td char="." align="char" colspan="1" rowspan="1">48</td><td align="left" colspan="1" rowspan="1">12.9</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Place of residence</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Urban</td><td char="." align="char" colspan="1" rowspan="1">219</td><td align="left" colspan="1" rowspan="1">58.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Rural</td><td char="." align="char" colspan="1" rowspan="1">154</td><td align="left" colspan="1" rowspan="1">41.3</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Average monthly income (Ugandan shilling</bold>
<bold><italic toggle="yes">UGX</italic></bold>
<bold>)</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;500,000</td><td char="." align="char" colspan="1" rowspan="1">291</td><td align="left" colspan="1" rowspan="1">78.0</td></tr><tr><td align="left" colspan="1" rowspan="1">&gt;&#8201;500,000</td><td char="." align="char" colspan="1" rowspan="1">82</td><td align="left" colspan="1" rowspan="1">22.0</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Duration with HIV</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;5 years</td><td char="." align="char" colspan="1" rowspan="1">124</td><td align="left" colspan="1" rowspan="1">33.2</td></tr><tr><td align="left" colspan="1" rowspan="1">5&#8211;10 years</td><td char="." align="char" colspan="1" rowspan="1">118</td><td align="left" colspan="1" rowspan="1">31.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&gt;&#8201;10years</td><td char="." align="char" colspan="1" rowspan="1">131</td><td align="left" colspan="1" rowspan="1">35.2</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Currently on ART</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td char="." align="char" colspan="1" rowspan="1">265</td><td align="left" colspan="1" rowspan="1">71.0</td></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td char="." align="char" colspan="1" rowspan="1">108</td><td align="left" colspan="1" rowspan="1">29.0</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Drug adherence (265)</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">High</td><td char="." align="char" colspan="1" rowspan="1">179</td><td align="left" colspan="1" rowspan="1">67.5</td></tr><tr><td align="left" colspan="1" rowspan="1">Medium</td><td char="." align="char" colspan="1" rowspan="1">69</td><td align="left" colspan="1" rowspan="1">26</td></tr><tr><td align="left" colspan="1" rowspan="1">Low</td><td char="." align="char" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">6.5</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>WHO HIV stage</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Stage I</td><td char="." align="char" colspan="1" rowspan="1">170</td><td align="left" colspan="1" rowspan="1">45.6</td></tr><tr><td align="left" colspan="1" rowspan="1">Stage II</td><td char="." align="char" colspan="1" rowspan="1">127</td><td align="left" colspan="1" rowspan="1">34.0</td></tr><tr><td align="left" colspan="1" rowspan="1">Stage III</td><td char="." align="char" colspan="1" rowspan="1">43</td><td align="left" colspan="1" rowspan="1">11.5</td></tr><tr><td align="left" colspan="1" rowspan="1">Stage IV</td><td char="." align="char" colspan="1" rowspan="1">33</td><td align="left" colspan="1" rowspan="1">8.8</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Viral load (copies /ml)</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&gt;&#8201;1000 copies</td><td char="." align="char" colspan="1" rowspan="1">26</td><td align="left" colspan="1" rowspan="1">7.0</td></tr><tr><td align="left" colspan="1" rowspan="1">200&#8211;1000 copies</td><td char="." align="char" colspan="1" rowspan="1">91</td><td align="left" colspan="1" rowspan="1">24.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;200 copies</td><td char="." align="char" colspan="1" rowspan="1">256</td><td align="left" colspan="1" rowspan="1">68.6</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>CD4 count (cells/mm</bold>
<sup><bold>3</bold></sup>
<bold>)</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8805;&#8201;500</td><td char="." align="char" colspan="1" rowspan="1">240</td><td align="left" colspan="1" rowspan="1">64.3</td></tr><tr><td align="left" colspan="1" rowspan="1">200&#8211;499</td><td char="." align="char" colspan="1" rowspan="1">91</td><td align="left" colspan="1" rowspan="1">24.4</td></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;200</td><td char="." align="char" colspan="1" rowspan="1">42</td><td align="left" colspan="1" rowspan="1">11.3</td></tr></tbody></table><table-wrap-foot><p>ART: Antiretroviral Therapy; BMI: Body Mass Index; HIV: Human Immunodeficiency Virus; UGX: Ugandan shillings; WHO: World Health Organization</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec15"><title>The prevalence of hypoalbuminemia among HIV-infected patients at LRRH</title><p id="Par41">The overall prevalence of hypoalbuminemia in patients with HIV was 19.6% (73/373) (95%CI: 17.8&#8211;21.7%).</p><p id="Par42">Correlation between hypoalbuminemia and CD4 count among HIV-infected patients.</p><p id="Par43">A moderate positive correlation between serum albumin and CD4 cell count was observed, with a Spearman&#8217;s rank correlation coefficient of 0.43 and it was a statistically significant p value of &lt;&#8201;0.001.</p></sec><sec id="Sec155"><title>Determinants of hypoalbuminemia among patients with HIV attending ART clinic LRRH</title><p id="Par44">The determinants of hypoalbuminemia were analyzed using both bivariate and multivariate logistic regression models. At the bivariate logistic regression level, variables with a p-value&#8201;&lt;&#8201;0.2 were entered into the multivariable model for further analysis. The results of these analyses are presented in (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).</p><p id="Par45">The results from the multivariate logistic regression model in (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>) indicate that patients with no formal of education [AOR&#8201;=&#8201;2.03, 95%CI&#8201;=&#8201;1.69&#8211;2.07, <italic toggle="yes">P</italic>&#8201;=&#8201;0.03] had higher odds of hypoalbuminemia than those who had tertiary/university education level. Patients who were not on ART had higher odds of Hypoalbuminemia [AOR&#8201;=&#8201;2.17, 95%CI&#8201;=&#8201;1.80&#8211;3.06, <italic toggle="yes">P</italic>&#8201;=&#8201;0.02] than those who were on ART. Additionally, WHO HIV stage IV was associated with greater odds of hypoalbuminemia [AOR&#8201;=&#8201;2.91, CI&#8201;=&#8201;2.13&#8211;3.66, <italic toggle="yes">P</italic>&#8201;=&#8201;0.01].</p><p id="Par46">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Bivariate and multivariate logistic regression analyses of factors associated with hypoalbuminemia among HIV-infected patients attending Lira regional referral Hospital(<italic toggle="yes">N</italic>&#8201;=&#8201;373)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variable</th><th align="left" colspan="2" rowspan="1">Yes*<break/>73(19.6%)</th><th align="left" colspan="1" rowspan="1">COR(95% CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th><th align="left" colspan="1" rowspan="1">AOR(95% CI)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<bold>Age categories</bold>
</td><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;30 years</td><td align="left" colspan="2" rowspan="1">16(21.9)</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">30&#8211;40 years</td><td align="left" colspan="2" rowspan="1">23(31.5)</td><td align="left" colspan="1" rowspan="1">1.41(0.43&#8211;2.42)</td><td align="left" colspan="1" rowspan="1">0.18</td><td align="left" colspan="1" rowspan="1">1.63(0.21&#8211;3.56)</td><td align="left" colspan="1" rowspan="1">0.38</td></tr><tr><td align="left" colspan="1" rowspan="1">41&#8211;50 years</td><td align="left" colspan="2" rowspan="1">22(30.1)</td><td align="left" colspan="1" rowspan="1">1.54(0.31&#8211;1.97)</td><td align="left" colspan="1" rowspan="1">0.24</td><td align="left" colspan="1" rowspan="1">1.79(0.38&#8211;2.26)</td><td align="left" colspan="1" rowspan="1">0.29</td></tr><tr><td align="left" colspan="1" rowspan="1">&gt;&#8201;50years</td><td align="left" colspan="2" rowspan="1">12(16.4)</td><td align="left" colspan="1" rowspan="1">0.89(0.06&#8211;0.95)</td><td align="left" colspan="1" rowspan="1">0.02</td><td align="left" colspan="1" rowspan="1">1.96(0.87&#8211;2.77)</td><td align="left" colspan="1" rowspan="1">0.84</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Education level</bold>
</td><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Tertiary/University</td><td align="left" colspan="2" rowspan="1">13(17.8)</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Secondary</td><td align="left" colspan="2" rowspan="1">10(13.7)</td><td align="left" colspan="1" rowspan="1">0.45(0.31&#8211;2.37)</td><td align="left" colspan="1" rowspan="1">0.31</td><td align="left" colspan="1" rowspan="1">0.39(0.65&#8211;2.81)</td><td align="left" colspan="1" rowspan="1">0.11</td></tr><tr><td align="left" colspan="1" rowspan="1">Primary</td><td align="left" colspan="2" rowspan="1">21(28.8)</td><td align="left" colspan="1" rowspan="1">0.88(0.54&#8211;1.95)</td><td align="left" colspan="1" rowspan="1">0.24</td><td align="left" colspan="1" rowspan="1">0.08(0.41&#8211;1.40)</td><td align="left" colspan="1" rowspan="1">0.15</td></tr><tr><td align="left" colspan="1" rowspan="1">No formal education</td><td align="left" colspan="2" rowspan="1">29(39.7)</td><td align="left" colspan="1" rowspan="1">2.41(1.54&#8211;3.82)</td><td align="left" colspan="1" rowspan="1">0.02</td><td align="left" colspan="1" rowspan="1">2.03(1.69&#8211;2.07)</td><td align="left" colspan="1" rowspan="1">
<bold>0.03*</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Marital status</bold>
</td><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Married</td><td align="left" colspan="2" rowspan="1">24(32.9)</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Single</td><td align="left" colspan="2" rowspan="1">33(45.2)</td><td align="left" colspan="1" rowspan="1">1.85(1.21&#8211;3.95)</td><td align="left" colspan="1" rowspan="1">0.03</td><td align="left" colspan="1" rowspan="1">1.27(0.88&#8211;1.72)</td><td align="left" colspan="1" rowspan="1">0.07</td></tr><tr><td align="left" colspan="1" rowspan="1">Divorced/widowed</td><td align="left" colspan="2" rowspan="1">16(21.9)</td><td align="left" colspan="1" rowspan="1">0.76(0.22&#8211;1.97)</td><td align="left" colspan="1" rowspan="1">0.63</td><td align="left" colspan="1" rowspan="1">0.58(0.18&#8211;1.87)</td><td align="left" colspan="1" rowspan="1">0.49</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Monthly income (UGX)</bold>
</td><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;500,000</td><td align="left" colspan="2" rowspan="1">51(69.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&gt;&#8201;500,000</td><td align="left" colspan="2" rowspan="1">22(30.1)</td><td align="left" colspan="1" rowspan="1">1.72(1.03&#8211;2.95)</td><td align="left" colspan="1" rowspan="1">0.04</td><td align="left" colspan="1" rowspan="1">1.41(0.27&#8211;3.93)</td><td align="left" colspan="1" rowspan="1">0.21</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Patient on ART</bold>
</td><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="2" rowspan="1">56(76.7)</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">No</td><td align="left" colspan="2" rowspan="1">17(23.3)</td><td align="left" colspan="1" rowspan="1">15.71(5.11&#8211;17.4)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">2.17(1.80&#8211;3.06)</td><td align="left" colspan="1" rowspan="1">
<bold>0.02*</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Duration with HIV/AIDS</bold>
</td><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&lt;&#8201;5 years</td><td align="left" colspan="2" rowspan="1">23(31.5)</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">5&#8211;10 years</td><td align="left" colspan="2" rowspan="1">15(20.5)</td><td align="left" colspan="1" rowspan="1">0.64(0.29&#8211;2.75)</td><td align="left" colspan="1" rowspan="1">0.21</td><td align="left" colspan="1" rowspan="1">1.93(0.25&#8211;2.66)</td><td align="left" colspan="1" rowspan="1">0.29</td></tr><tr><td align="left" colspan="1" rowspan="1">&gt;&#8201;10years</td><td align="left" colspan="2" rowspan="1">35(47.9)</td><td align="left" colspan="1" rowspan="1">1.60 (1.02&#8211;2.94)</td><td align="left" colspan="1" rowspan="1">0.04</td><td align="left" colspan="1" rowspan="1">1.10(0.92&#8211;2.75)</td><td align="left" colspan="1" rowspan="1">0.18</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>WHO HIV staging</bold>
</td><td align="left" colspan="2" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Stage I</td><td align="left" colspan="2" rowspan="1">41(56.2)</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Stage II</td><td align="left" colspan="2" rowspan="1">15(20.5)</td><td align="left" colspan="1" rowspan="1">1.18(0.13&#8211;3.66)</td><td align="left" colspan="1" rowspan="1">0.19</td><td align="left" colspan="1" rowspan="1">1.34(0.81&#8211;1.97)</td><td align="left" colspan="1" rowspan="1">0.18</td></tr><tr><td align="left" colspan="1" rowspan="1">Stage III</td><td align="left" colspan="2" rowspan="1">12(16.4)</td><td align="left" colspan="1" rowspan="1">2.92(0.21&#8211;2.15)</td><td align="left" colspan="1" rowspan="1">0.71</td><td align="left" colspan="1" rowspan="1">0.99(0.18&#8211;2.11)</td><td align="left" colspan="1" rowspan="1">0.37</td></tr><tr><td align="left" colspan="1" rowspan="1">Stage IV</td><td align="left" colspan="2" rowspan="1">5(6.8)</td><td align="left" colspan="1" rowspan="1">9.13(4.06&#8211;10.70)</td><td align="left" colspan="1" rowspan="1">0.006</td><td align="left" colspan="1" rowspan="1">2.91(2.13&#8211;3.66)</td><td align="left" colspan="1" rowspan="1">
<bold>0.01*</bold>
</td></tr><tr><td align="left" colspan="2" rowspan="1">
<bold>Viral load copies/ml</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="2" rowspan="1">&gt;&#8201;1000</td><td align="left" colspan="1" rowspan="1">19(26.0)</td><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="2" rowspan="1">200&#8211;1000</td><td align="left" colspan="1" rowspan="1">28(38.4)</td><td align="left" colspan="1" rowspan="1">0.16(0.05&#8211;3.26)</td><td align="left" colspan="1" rowspan="1">0.14</td><td align="left" colspan="1" rowspan="1">0.41(0.15&#8211;2.26)</td><td align="left" colspan="1" rowspan="1">0.14</td></tr><tr><td align="left" colspan="2" rowspan="1">&lt;&#8201;1000</td><td align="left" colspan="1" rowspan="1">26(35.6)</td><td align="left" colspan="1" rowspan="1">0.04(0.01&#8211;0.98)</td><td align="left" colspan="1" rowspan="1">0.03</td><td align="left" colspan="1" rowspan="1">0.55(0.26&#8211;1.08)</td><td align="left" colspan="1" rowspan="1">0.07</td></tr><tr><td align="left" colspan="2" rowspan="1">
<bold>Drug adherence</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="2" rowspan="1">High</td><td align="left" colspan="1" rowspan="1">30(41.1)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1.00</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="2" rowspan="1">Medium</td><td align="left" colspan="1" rowspan="1">34(46.6)</td><td align="left" colspan="1" rowspan="1">4.8(2.1&#8211;6.26)</td><td align="left" colspan="1" rowspan="1">0.31</td><td align="left" colspan="1" rowspan="1">5.29(0.76&#8211;9.76)</td><td align="left" colspan="1" rowspan="1">0.09</td></tr><tr><td align="left" colspan="2" rowspan="1">Low</td><td align="left" colspan="1" rowspan="1">9(12.3)</td><td align="left" colspan="1" rowspan="1">5.6(3.02&#8211;8.30)</td><td align="left" colspan="1" rowspan="1">&lt;&#8201;0.001</td><td align="left" colspan="1" rowspan="1">4.65(0.47&#8211;12.66)</td><td align="left" colspan="1" rowspan="1">0.17</td></tr></tbody></table><table-wrap-foot><p>ART: Antiretroviral Therapy; AOR: adjusted odds ratio; COR: crude odds ratio; 95% CI: 95% confidence interval; HIV: Human Immunodeficiency Virus; P-value&#8201;&lt;&#8201;0.05 were considered statistically significant; UGX: Ugandan shillings; WHO: World Health Organization; Yes: patients with hypoalbuminemia;</p></table-wrap-foot></table-wrap>
</p></sec></sec><sec id="Sec16"><title>Discussion</title><p id="Par47">The prevalence of hypoalbuminemia among HIV-infected patients attending Lira Regional Referral Hospital (LRRH) was found to be high at 19.6% (73/373). This finding highlights the importance of hypoalbuminemia as a common biochemical abnormality in HIV-infected individuals. The findings of our current study are slightly greater than those of a cross-sectional study conducted in Brazil, which reported a hypoalbuminemia prevalence of 11.7% among HIV-positive outpatients [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par48">However, the prevalence is lower than that reported in a study conducted in India, where 66.3% of the subjects had hypoalbuminemia [<xref ref-type="bibr" rid="CR14">14</xref>]. However, it is important to note that in the Indian study, most participants had a CD4 count of less than 350 cells/mm<sup>3</sup>, whereas in the present study, 64.3% of the participants had a CD4 count of more than 500 cells/mm<sup>3</sup>. Similarly higher prevalence of hypoalbuminemia was also reported in other studies conducted in India [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR16">16</xref>&#8211;<xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par49">A prospective cohort study conducted in Tanzania revealed that 39.5% of HIV infected patients had hypoalbuminemia at baseline [<xref ref-type="bibr" rid="CR10">10</xref>]. This prevalence is slightly higher than that obtained in the present study. The Tanzania study was a prospective cohort study with a larger sample size. Moreover, in the Tanzanian study, serum albumin was measured at ART initiation, whereas in our present study, serum albumin was measured in all participants, regardless of ART status.</p><p id="Par50">The current study revealed a moderate positive correlation between the serum albumin level and CD4 count among HIV-infected patients, with a statistically significant p value (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). This finding indicates that as the serum albumin level increases, the CD4 count tends to increase, and the opposite is true of low serum albumin, which is associated with a lower CD4 count. The findings of our current study agree with those of a study by Balgi V et al.(2019), which also revealed a strong correlation between the serum albumin concentration and the CD4 count, with a statistically significant p value of &lt;&#8201;0.003<sup>14</sup>. Similarly, a study conducted in India reported a strong positive correlation between the CD4 count and the serum albumin concentration, which was statistically significant <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.0001<sup>18</sup>. Both studies support our findings. Therefore, a low CD4 count is associated with decreased or reduced serum albumin levels, both of which indicate advanced disease. Additionally, other studies revealed an association between the serum albumin concentration and the CD4 count which are similar findings to our current study [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par51">Conversely, a cross-sectional study conducted in Cameroon reported a weak negative correlation between the CD4 count and total protein [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par52">The findings of the present study highlight that hypoalbuminemia is associated with advanced HIV disease, and lower CD4 counts and high viral load counts were observed in patients with hypoalbuminemia. Therefore, these findings suggest that the serum albumin concentration could be a useful biomarker for monitoring immune status and disease progression in HIV-infected patients. Additionally, since serum albumin testing is inexpensive and widely available, it could be beneficial and particularly useful in resource-limited settings.</p><p id="Par53">Patients who were not on ART had greater odds of having hypoalbuminemia than those on ART drugs. Similarly, Leal et al. reported that patients who were not exposed to ART were more likely to have hypoalbuminemia [<xref ref-type="bibr" rid="CR5">5</xref>]. The findings of the present study highlight that ART initiation or being on ART is crucial in patients with HIV. Several studies highlighted changes or increased plasma albumin concentrations after initiation of Highly Active Antiretroviral Therapy (HAART) in patients living with HIV [<xref ref-type="bibr" rid="CR22">22</xref>]. ART in HIV patients leads to viral load suppression and improved immune function, restoring the CD4 count [<xref ref-type="bibr" rid="CR23">23</xref>].</p><p id="Par54">The current study also revealed that patients with no formal education had greater odds of hypoalbuminemia than did those with tertiary/university education. However, these findings shed light on the need for longitudinal studies to assess the link between low serum albumin and low educational levels in patients with HIV. Education is closely linked to health literacy, access to healthcare, and the ability to make informed decisions about nutrition and treatment adherence.</p><p id="Par55">The present study revealed that patients in WHO HIV stage IV were nearly three times more likely to have hypoalbuminemia than were those in stage I. Similar findings were reported that participants with WHO HIV stage IV had more odds of hypoalbuminemia than those in stage I [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Advanced HIV disease leads to systemic inflammation and increased rates of opportunistic infection, which contributes to hypoalbuminemia in patients with HIV [<xref ref-type="bibr" rid="CR24">24</xref>]. Studies have shown that the serum albumin concentration is a predictor of the progression of HIV-related advanced disease and AIDS-related mortality [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p></sec><sec id="Sec17"><title>Conclusions</title><p id="Par56">This study identified a high prevalence of hypoalbuminemia (19.6%) among PLWHIV at Lira Regional Referral Hospital, Northern Uganda, with a higher risk observed among patients who were not on ART, those with no formal education, and those with WHO HIV stage IV. These findings underscore the potential benefits of routine serum albumin screening in PLWHIV. Therefore, this study suggests that serum albumin, being inexpensive and widely accessible, could serve as a valuable prognostic tool for monitoring immune status and disease progression, particularly in resource-limited settings. However, the cross-sectional design limits causal inferences, and the single-center setting may restrict generalizability. Further multi-center longitudinal studies are recommended to explore causal relationships, disease progression, and short-term mortality in PLWHIV to validate these findings and inform broader public health strategies.</p></sec><sec id="Sec18" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="12981_2025_757_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p><p>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xlink:href="12981_2025_757_MOESM2_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Material 2</p></caption></media></supplementary-material>
</p><p>
<supplementary-material content-type="local-data" id="MOESM3" position="float" orientation="portrait"><media xlink:href="12981_2025_757_MOESM3_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Material 3</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>A.A.A is the principal investigator, formulated and designed the study, collected and analyzed data, and wrote the manuscript draft. O.N, A.M.H and M.E.M supervised the study and approved the manuscript. H.A.H, V.E.M, H.M.SH.O, A.A.A and M.J took part in the discussion of the study results. All the co-authors agreed to submit the study in BMC&#8211;AIDS Research and Therapy.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>There was no funding.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Data is available on request by contacting corresponding author. Abukar Ali Ahmedahmed.abukar@studwc.kiu.ac.ugabukr252@gmail.com.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par57">Ethical approval for the study was granted by the Kampala International University Research Ethics Committee (Ref no: <bold>KIU-2024-401</bold>). All the participants were requested to sign the consent form, as evidenced by the participants&#8217; signature.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par58">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par59">The authors declare no competing interests.</p></notes><notes id="FPar4"><title>Clinical trial number</title><p id="Par60">Not applicable.</p></notes></notes><glossary><title>Abbreviations</title><def-list><def-item><term>AIDs</term><def><p id="Par61">Acquired immunodeficiency syndrome</p></def></def-item><def-item><term>ART</term><def><p id="Par62">Anti-retroviral treatment</p></def></def-item><def-item><term>HAART</term><def><p id="Par63">Highly Active Antiretroviral Therapy</p></def></def-item><def-item><term>HIV</term><def><p id="Par64">Human immunodeficiency virus</p></def></def-item><def-item><term>LRRH</term><def><p id="Par65">Lira regional referral hospital</p></def></def-item><def-item><term>PI</term><def><p id="Par66">principal investigator</p></def></def-item><def-item><term>PLWHIV</term><def><p id="Par67">People living with HIV</p></def></def-item><def-item><term>WHO</term><def><p id="Par68">World Health Organization</p></def></def-item></def-list></glossary><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>S</given-names></name><name name-style="western"><surname>Jamra</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hawaldar</surname><given-names>S</given-names></name><name name-style="western"><surname>Meshram</surname><given-names>A</given-names></name></person-group><article-title>Study of serum albumin as surrogate marker of immune suppression in patients living with HIV and AIDS</article-title><source>Int J Adv Med</source><year>2016</year><volume>3</volume><issue>2</issue><fpage>152</fpage><lpage>6</lpage></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Sharma S, Jamra Y, Hawaldar S, Meshram A. Study of serum albumin as surrogate marker of immune suppression in patients living with HIV and AIDS. Int J Adv Med. 2016;3(2):152&#8211;6.</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sundaram</surname><given-names>M</given-names></name><name name-style="western"><surname>Srinivas</surname><given-names>CN</given-names></name><name name-style="western"><surname>Shankar</surname><given-names>EM</given-names></name><name name-style="western"><surname>Balakrishnan</surname><given-names>P</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>S</given-names></name><name name-style="western"><surname>Kumarasamy</surname><given-names>N</given-names></name></person-group><article-title>Cofactors for low serum albumin levels among HIV-infected individuals in Southern India</article-title><source>J Int Assoc Physicians AIDS Care</source><year>2009</year><volume>8</volume><issue>3</issue><fpage>161</fpage><lpage>4</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1545109708330787</pub-id><pub-id pub-id-type="pmid">19176315</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Sundaram M, Srinivas CN, Shankar EM, Balakrishnan P, Solomon S, Kumarasamy N. Cofactors for low serum albumin levels among HIV-infected individuals in Southern India. J Int Assoc Physicians AIDS Care. 2009;8(3):161&#8211;4.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1545109708330787</pub-id><pub-id pub-id-type="pmid">19176315</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abubakar</surname><given-names>M</given-names></name><name name-style="western"><surname>Abduljalil</surname><given-names>M</given-names></name><name name-style="western"><surname>Bola-Alaka</surname><given-names>G</given-names></name><name name-style="western"><surname>Nasiru</surname><given-names>Y</given-names></name></person-group><article-title>Influence of ARVs on some biochemical changes in liver Non enzymatic markers of HIV positive patients attending specialist hospital sokoto, Nigeria</article-title><source>Niger J Basic Appl Sci</source><year>2015</year><volume>23</volume><issue>1</issue><fpage>45</fpage></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Abubakar M, Abduljalil M, Bola-Alaka G, Nasiru Y. Influence of ARVs on some biochemical changes in liver Non enzymatic markers of HIV positive patients attending specialist hospital sokoto, Nigeria. Niger J Basic Appl Sci. 2015;23(1):45.</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Poudel-Tandukar K, Jacelon CS, Bertone-Johnson ER, Palmer PH, Poudel KC. Serum albumin levels and depression in people living with Human Immunodeficiency Virus infection: a cross-sectional study. J Psychosom Res [Internet]. 2017;101(April):38&#8211;43. Available from: 10.1016/j.jpsychores.2017.08.005<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychores.2017.08.005</pub-id><pub-id pub-id-type="pmid">28867422</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leal</surname><given-names>JA</given-names></name><name name-style="western"><surname>Fausto</surname><given-names>MA</given-names></name><name name-style="western"><surname>Carneiro</surname><given-names>M</given-names></name><name name-style="western"><surname>Tubinamb&#225;s</surname><given-names>U</given-names></name></person-group><article-title>Prevalence of hypoalbuminemia in outpatients with HIV/AIDS</article-title><source>Rev Soc Bras Med Trop</source><year>2018</year><volume>51</volume><issue>2</issue><fpage>203</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">29768554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/0037-8682-0093-2017</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Leal JA, Fausto MA, Carneiro M, Tubinamb&#225;s U. Prevalence of hypoalbuminemia in outpatients with HIV/AIDS. Rev Soc Bras Med Trop. 2018;51(2):203&#8211;6.<pub-id pub-id-type="pmid">29768554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/0037-8682-0093-2017</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiggundu</surname><given-names>T</given-names></name><name name-style="western"><surname>Kalyesubula</surname><given-names>R</given-names></name><name name-style="western"><surname>Andia-Biraro</surname><given-names>I</given-names></name><name name-style="western"><surname>Makanga</surname><given-names>G</given-names></name><name name-style="western"><surname>Byakika-Kibwika</surname><given-names>P</given-names></name></person-group><article-title>Prevalence of microalbuminuria and associated factors among HIV&#8211;&#8201;infected ART Na&#239;ve patients at Mulago hospital: a cross-sectional study in Uganda</article-title><source>BMC Nephrol</source><year>2020</year><volume>21</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12882-020-02091-2</pub-id><pub-id pub-id-type="pmcid">PMC7574295</pub-id><pub-id pub-id-type="pmid">33081706</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Kiggundu T, Kalyesubula R, Andia-Biraro I, Makanga G, Byakika-Kibwika P. Prevalence of microalbuminuria and associated factors among HIV&#8211;&#8201;infected ART Na&#239;ve patients at Mulago hospital: a cross-sectional study in Uganda. BMC Nephrol. 2020;21(1):1&#8211;6.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12882-020-02091-2</pub-id><pub-id pub-id-type="pmcid">PMC7574295</pub-id><pub-id pub-id-type="pmid">33081706</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Zhang J, Xie Z, Cai S, Qin S, Ruan G, Lu A et al. Hypoalbuminemia predicts inferior outcome in patients with AIDS-related lymphoma. Infect Agent Cancer [Internet]. 2022;17(1):1&#8211;8. Available from: 10.1186/s13027-022-00448-w<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13027-022-00448-w</pub-id><pub-id pub-id-type="pmcid">PMC9206320</pub-id><pub-id pub-id-type="pmid">35717275</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Serum Albumin and Short-Term Risk for Mortality and Cardiovascular Disease among HIV-Infected Veterans By. Joshua Paul Lajos Lang A thesis submitted in partial satisfaction of the requirements for the degree of Master of Science in Health and Medical Sci. 2014.</mixed-citation></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maemun</surname><given-names>S</given-names></name><name name-style="western"><surname>Mariana</surname><given-names>N</given-names></name><name name-style="western"><surname>Wijaya</surname><given-names>SO</given-names></name><name name-style="western"><surname>Oktavia</surname><given-names>D</given-names></name><name name-style="western"><surname>Lisdawati</surname><given-names>V</given-names></name><name name-style="western"><surname>Rogayah</surname><given-names>R</given-names></name></person-group><article-title>Is hypoalbuminemia a predictor marker of mortality?</article-title><source>Heal Sci J Indones</source><year>2020</year><volume>11</volume><issue>2</issue><fpage>121</fpage><lpage>5</lpage></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Maemun S, Mariana N, Wijaya SO, Oktavia D, Lisdawati V, Rogayah R. Is hypoalbuminemia a predictor marker of mortality? Heal Sci J Indones. 2020;11(2):121&#8211;5.</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudfeld</surname><given-names>CR</given-names></name><name name-style="western"><surname>Isanaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Aboud</surname><given-names>S</given-names></name><name name-style="western"><surname>Mugusi</surname><given-names>FM</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Chalamilla</surname><given-names>GE</given-names></name><etal/></person-group><article-title>Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among Tanzanians initiating antiretroviral therapy</article-title><source>J Infect Dis</source><year>2013</year><volume>207</volume><issue>9</issue><fpage>1370</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23319741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jit027</pub-id><pub-id pub-id-type="pmcid">PMC3610420</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Sudfeld CR, Isanaka S, Aboud S, Mugusi FM, Wang M, Chalamilla GE, et al. Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among Tanzanians initiating antiretroviral therapy. J Infect Dis. 2013;207(9):1370&#8211;8.<pub-id pub-id-type="pmid">23319741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jit027</pub-id><pub-id pub-id-type="pmcid">PMC3610420</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Huang R, Shi Y, Wang J, Zhao H, Huang J, Wu L et al. Association between admission serum albumin and 12-weeks mortality in patients with late AIDS/HIV diagnosis: a retrospective cohort study. Sci Rep [Internet]. 2024;14(1):1&#8211;9. Available from: 10.1038/s41598-024-69282-x<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-024-69282-x</pub-id><pub-id pub-id-type="pmcid">PMC11316092</pub-id><pub-id pub-id-type="pmid">39122884</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Mal S, Rajasthan D, Resident S, College GM, INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH ROLE, OF SERUM ALBUMIN LEVEL COMPARED TO CD4&#8201;+&#8201;CELL COUNT AS A MARKER OF IMMUNOSUPPRESSION IN HIV / AIDS PATIENTS Medicine Shivcharan Jelia. * Om Prakash Meena. 2020;(2277):37&#8211;9.</mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Sundeep KS, Rao BB, ROLE OF SERUM ALBUMIN LEVEL COMPARED, TO CD4 COUNT AS A MARKER OF IMMUNOSUPPRESSION IN HIV/AIDS PATIENTS. 2020; Available from: 10.24327/ijrsr.2020.1104.5276</mixed-citation></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balgi</surname><given-names>V</given-names></name><name name-style="western"><surname>Arun</surname><given-names>A</given-names></name><name name-style="western"><surname>Nayak</surname><given-names>V</given-names></name><name name-style="western"><surname>D K S</surname><given-names>BP</given-names></name></person-group><article-title>Study of serum albumin level in subjects with HIV infection, in relation to CD 4 count, as a marker of immune suppression</article-title><source>Int J Contemp Med Res [IJCMR]</source><year>2019</year><volume>6</volume><issue>12</issue><fpage>10</fpage><lpage>2</lpage></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Balgi V, Arun A, Nayak V, D K S BP. Study of serum albumin level in subjects with HIV infection, in relation to CD 4 count, as a marker of immune suppression. Int J Contemp Med Res [IJCMR]. 2019;6(12):10&#8211;2.</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ronit</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S</given-names></name><name name-style="western"><surname>Baker</surname><given-names>JV</given-names></name><name name-style="western"><surname>Mngqibisa</surname><given-names>R</given-names></name><name name-style="western"><surname>Delory</surname><given-names>T</given-names></name><name name-style="western"><surname>Caldeira</surname><given-names>L</given-names></name><etal/></person-group><article-title>Serum albumin as a prognostic marker for serious Non-AIDS endpoints in the strategic timing of antiretroviral treatment (START) study</article-title><source>J Infect Dis</source><year>2018</year><volume>217</volume><issue>3</issue><fpage>405</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">29244111</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jix350</pub-id><pub-id pub-id-type="pmcid">PMC5853310</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Ronit A, Sharma S, Baker JV, Mngqibisa R, Delory T, Caldeira L, et al. Serum albumin as a prognostic marker for serious Non-AIDS endpoints in the strategic timing of antiretroviral treatment (START) study. J Infect Dis. 2018;217(3):405&#8211;12.<pub-id pub-id-type="pmid">29244111</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jix350</pub-id><pub-id pub-id-type="pmcid">PMC5853310</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>J</given-names></name><name name-style="western"><surname>Scherzer</surname><given-names>R</given-names></name><name name-style="western"><surname>Weekley</surname><given-names>CC</given-names></name><name name-style="western"><surname>Tien</surname><given-names>PC</given-names></name><name name-style="western"><surname>Grunfeld</surname><given-names>C</given-names></name><name name-style="western"><surname>Shlipak</surname><given-names>MG</given-names></name></person-group><article-title>Serum albumin and short-term risk for mortality and cardiovascular disease among HIV-infected veterans</article-title><source>Aids</source><year>2013</year><volume>27</volume><issue>8</issue><fpage>1339</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">23343914</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0b013e32835f1dd6</pub-id><pub-id pub-id-type="pmcid">PMC4026018</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Lang J, Scherzer R, Weekley CC, Tien PC, Grunfeld C, Shlipak MG. Serum albumin and short-term risk for mortality and cardiovascular disease among HIV-infected veterans. Aids. 2013;27(8):1339&#8211;43.<pub-id pub-id-type="pmid">23343914</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0b013e32835f1dd6</pub-id><pub-id pub-id-type="pmcid">PMC4026018</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>H</given-names></name><name name-style="western"><surname>Mangla</surname><given-names>D</given-names></name><name name-style="western"><surname>Singh</surname><given-names>J</given-names></name><name name-style="western"><surname>Neki</surname><given-names>NS</given-names></name></person-group><article-title>Role of serum albumin level compared to CD4 cell count as a marker of immunosuppression in HIV/AIDS patients</article-title><source>Int J Curr Res Biol Med</source><year>2017</year><volume>4</volume><issue>11</issue><fpage>495</fpage><lpage>502</lpage></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Singh H, Mangla D, Singh J, Neki NS. Role of serum albumin level compared to CD4 cell count as a marker of immunosuppression in HIV/AIDS patients. Int J Curr Res Biol Med. 2017;4(11):495&#8211;502.</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Mehta D, Nitin DSB. View of CORRELATION OF SERUM ALBUMIN AND CD4 COUNT AS A MARKER OF IMMUNOSUPRESSION IN PATIENT LIVING WITH.pdf. 2024.</mixed-citation></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alvarez-Uria</surname><given-names>G</given-names></name><name name-style="western"><surname>Midde</surname><given-names>M</given-names></name><name name-style="western"><surname>Pakam</surname><given-names>R</given-names></name><name name-style="western"><surname>Naik</surname><given-names>PK</given-names></name></person-group><article-title>Authors&#8217; reply: serum albumin for tuberculosis in HIV infected patients eligible for antiretroviral therapy</article-title><source>BioImpacts</source><year>2013</year><volume>3</volume><issue>4</issue><fpage>201</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">24455485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5681/bi.2013.034</pub-id><pub-id pub-id-type="pmcid">PMC3892741</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Alvarez-Uria G, Midde M, Pakam R, Naik PK. Authors&#8217; reply: serum albumin for tuberculosis in HIV infected patients eligible for antiretroviral therapy. BioImpacts. 2013;3(4):201&#8211;2.<pub-id pub-id-type="pmid">24455485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5681/bi.2013.034</pub-id><pub-id pub-id-type="pmcid">PMC3892741</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puleh</surname><given-names>SS</given-names></name><name name-style="western"><surname>Ikwara</surname><given-names>EA</given-names></name><name name-style="western"><surname>Namutebi</surname><given-names>S</given-names></name><name name-style="western"><surname>Nakero</surname><given-names>L</given-names></name><name name-style="western"><surname>Mwesiga</surname><given-names>G</given-names></name><name name-style="western"><surname>Isabirye</surname><given-names>R</given-names></name><etal/></person-group><article-title>Knowledge and perceptions of primary healthcare providers towards integration of antiretroviral therapy (ART) services at departmental levels at selected health facilities Lira district, Uganda</article-title><source>BMC Health Serv Res</source><year>2023</year><volume>23</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">37095491</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12913-023-09388-6</pub-id><pub-id pub-id-type="pmcid">PMC10123554</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Puleh SS, Ikwara EA, Namutebi S, Nakero L, Mwesiga G, Isabirye R, et al. Knowledge and perceptions of primary healthcare providers towards integration of antiretroviral therapy (ART) services at departmental levels at selected health facilities Lira district, Uganda. BMC Health Serv Res. 2023;23(1):1&#8211;10.<pub-id pub-id-type="pmid">37095491</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12913-023-09388-6</pub-id><pub-id pub-id-type="pmcid">PMC10123554</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Abba A, Fokam J, Kamgaing RS, Yimga JF, Kae AC, Nka AD et al. Correlation between the immuno-virological response and the nutritional profile of treatment-experienced HIV-infected patients in the East region of Cameroon. PLoS One [Internet]. 2021;16(5 May):1&#8211;15. Available from: 10.1371/journal.pone.0229550<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0229550</pub-id><pub-id pub-id-type="pmcid">PMC8118549</pub-id><pub-id pub-id-type="pmid">33983976</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Bisaso KR, Owen JS, Ojara FW, Namuwenge PM, Mugisha A, Mbuagbaw L et al. Characterizing plasma albumin concentration changes in TB / HIV patients on anti retroviral and anti &#8211; tuberculosis therapy. 2014;(Tavill 1972):1&#8211;8.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40203-014-0003-9</pub-id><pub-id pub-id-type="pmcid">PMC4173069</pub-id><pub-id pub-id-type="pmid">25264502</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Nabatanzi R, Cose S, Joloba M, Jones SR, Nakanjako D. Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells. AIDS Res Ther [Internet]. 2018;15(1):1&#8211;8. Available from: 10.1186/s12981-018-0194-y<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12981-018-0194-y</pub-id><pub-id pub-id-type="pmcid">PMC5853105</pub-id><pub-id pub-id-type="pmid">29544508</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">Ronit A, Hatleberg CI, Ryom L, Bonnet F, El-Sadr W, Reiss P et al. Associations between serum albumin and serious non-AIDS events among people living with HIV. Vol. 32, Aids. 2018. 1837&#8211;1848 p.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000001900</pub-id><pub-id pub-id-type="pmid">29847331</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>